Background A growing number of preclinical studies have demonstrated that curcumin could
be a promising anticancer drug; however, poor bioavailability has been the major obstacle …

Background More and more preclinical studies support the idea that curcumin, a plant-
derived natural polyphenol, could be a promising anticancer drug. However, poor …

Although the anticancer role of curcumin has been extensively addressed in preclinical
research, only a few studies were carried out in humans, with conflicting results. The aim of …

Introduction: Curcumin has been extensively studied for its anti-cancer properties. While a
diverse array of in vitro and preclinical research support the prospect of curcumin use as an …

Dear Editor, Curcumin is a yellow–orange pigment obtained from the plant Curcuma longa.
The powdered rhizome of this plant, called turmeric, is a common ingredient in curry …

A number of preclinical studies have demonstrated anticancer effects for curcumin in various
types of tumors, including pancreatic cancer. Curcumin has anticancer effects both alone …

Background Curcumin is herbal compound that has been shown to have anti-cancer effects
in pre-clinical and clinical studies. The anti-cancer effects of curcumin include inhibiting the …

Curcumin, the key bioactive phytochemical present in turmeric (Curcuma longa L.), is the
most studied natural compound in cancer. Preclinical studies (in vitro and in vitro) and …

Abstract Background and Objectives Curcumin is the major bioactive component of turmeric,
but has poor oral bioavailability that limits its clinical applications. To improve the in vitro …

Curcumin, commonly called diferuloyl methane, is a hydrophobic polyphenol derived from
rhizome (turmeric) of the herb Curcuma longa. Extensive research over the last half century …